Norris Medicines Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	135	134	168	136	105	350
Market Cap Growth	-35.68%	-20.44%	23.38%	30.14%	-70.10%	437.69%
Enterprise Value	350	348	383	351	319	550
Last Close Price	13.50	13.35	16.78	13.60	10.45	34.95
PS Ratio	1.66	1.64	2.88	2.41	1.25	3.70
PB Ratio	-0.89	-0.88	-1.13	-1.00	-0.84	-3.27
P/FCF Ratio	23.77	23.51	34.17	80.65	8.94	-
P/OCF Ratio	23.37	23.11	32.90	80.11	8.71	-
EV/Sales Ratio	4.31	4.27	6.59	6.23	3.82	5.83
EV/EBITDA Ratio	49.30	48.94	-	-	34.52	-
EV/EBIT Ratio	159.59	158.42	-	-	108.08	-
EV/FCF Ratio	61.65	61.19	78.09	208.24	27.30	-
Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Debt / EBITDA Ratio	30.32	30.32	-	-	23.13	-
Debt / FCF Ratio	37.91	37.91	43.95	127.63	18.30	-
Net Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Net Debt / EBITDA Ratio	30.29	30.29	-97.40	-120.43	23.11	-334.03
Net Debt / FCF Ratio	37.88	37.88	43.87	127.41	18.28	-19.78
Asset Turnover	0.61	0.61	0.42	0.40	0.60	0.56
Inventory Turnover	1.06	1.06	0.83	0.72	1.25	1.48
Quick Ratio	0.13	0.13	0.14	0.12	0.14	0.16
Current Ratio	0.61	0.61	0.63	0.67	0.64	0.63
Return on Assets (ROA)	1.03%	1.03%	-3.38%	-3.36%	1.32%	-2.65%
Return on Capital Employed (ROCE)	6.50%	6.50%	-20.70%	-15.10%	4.90%	-9.70%
Earnings Yield	-2.08%	-2.10%	-7.37%	-8.72%	-16.74%	-9.34%
FCF Yield	4.21%	4.25%	2.93%	1.24%	11.19%	-3.05%
Buyback Yield / Dilution	-0.21%	-0.21%	-	-	-	-